Study Name:
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentre, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (DFP) (FAIR PARK II study)

Phase:
Phase 2 Clinical Trial

EudraCT number:
2015-003679-31

National Investigator Coordinator:
Prof. Doctor Joaquim Ferreira

Sponsor:
Centre Hospitalier Regional et Universitaire (CHRU) de Lille

Participating countries:
France, Czech Republic, Portugal, Austria, Germany, the Netherlands, Spain and United Kingdom

Sites in Portugal:
Centro Hospitalar Lisboa Norte – Hospital Santa Maria, Centro Hospitalar do Alto Ave, Centro Hospitalar Universitário de Coimbra

Status:
Recruitment